Britannia Life Sciences Inc. (CNSX:BLAB) entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited on April 7, 2022. Upon completion of the Additional ADSL Purchase, Britannia will own a 70% interest in ADSL, Britannia's largest operating subsidiary. Gowling WLG (UK) LLP and Bennett Jones LLP acted as legal advisor to Britannia Life Sciences Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 CAD | 0.00% | +25.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 8.89M | |
+13.21% | 8.15B | |
+3.16% | 7.52B | |
+12.30% | 6.65B | |
-5.71% | 3.73B | |
-6.99% | 3.72B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-37.22% | 958M | |
-15.02% | 876M |
- Stock Market
- Equities
- BLAB Stock
- News Britannia Life Sciences Inc.
- Britannia Life Sciences Inc. entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited.